A Practical Approach With Outcome for the Prognostic Assessment of Non–ST-Segment Elevation Chest Pain and Normal Troponin - 16/08/11
![](/templates/common/images/mail.png)
![](/templates/common/images/entites/204e.gif)
Résumé |
Patients with non–ST-elevation chest pain constitute a heterogeneous population. Our aim is to compare the outcome of patients with chest pain, non–ST-segment deviation, and normal troponin, categorized using a risk score, with that of patients with ST depression or troponin increase. A total of 1,449 patients with non–ST-elevation chest pain were evaluated. A validated risk score (using pain characteristics and risk factors) was applied to patients without ST depression or troponin increase. Accordingly, 4 risk categories were defined: group 1, no troponin increase, no ST depression, and risk score <3 points (n = 633); group 2, no troponin increase, no ST depression, but risk score ≥3 points (n = 158); group 3, no troponin increase, ST depression (n = 106); and group 4, troponin increase (n = 552). Median follow-up was 26 months, and the end point was death or myocardial infarction. Group 1 experienced fewer events at 30 days (1.7%, p = 0.0001) and long-term follow-up (9.4%, p = 0.0001) than groups 2 (10.8% and 26%), 3 (6.6% and 30%), and 4 (9.5% and 25%). Kaplan-Meier curves overlapped among groups 2, 3, and 4, whereas group 1 showed a flatter curve (p = 0.0001). Using multivariate analysis, risk group (group 1 vs remaining groups) predicted 30-day (p = 0.0003) and long-term (p = 0.0001) outcome. There were no differences among groups 2, 3, and 4. In conclusion, application of a risk score to patients without troponin increase or ST deviation identified a high-risk group with prognosis similar to that of patients with troponin increase or ST depression and affords a practical classification for the full spectrum of non–ST-elevation chest pain.
Le texte complet de cet article est disponible en PDF.Plan
This work was supported by the Instituto de Salud Carlos III (Spanish Public Health System, Spain) under the grant RECAVA-FIS and by the Fundación Española del Corazón (Sociedad Española de Cardiología, Spain) under the grant “Beca para Investigación Clínica y Básica en Cardiología 2005”, Madrid, Spain. |
Vol 99 - N° 6
P. 797-801 - mars 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?